Lupin, Inc., an India-based research-oriented pharmaceutical company, expanded its operations in Florida at the Coral Springs Corporate Park. The project is expected to create at least 45 high-skilled positions in Broward County.

The company settled into a space in Coral Springs with plans to open a new laboratory by the end of this year, according to Enterprise Florida. Lupin’s new facility will focus on the research and development of new drugs, bolstering Florida’s booming life science industry with its portfolio of generic and branded medicines.

Lupin’s Senior Vice President of Inhalation Research and Development, Dr. Xian-Ming Zeng, cites the ability to recruit high-quality scientists from the South Florida area as a strong motivator behind the decision to expand to South Florida. “Florida is perfectly positioned for Lupin to thrive. There is a unique opportunity to collaborate with the area’s universities and explore long-term recruitment solutions. Not only does this mean the cost of recruiting is lower but the resulting candidates are highly-trained and desirable as employees.”

Lupin is a U.S. owned subsidiary of Lupin Limited, a research-oriented pharmaceutical company that is headquartered in Mumbai, India. In the U.S., Lupin is the 5th largest generics player by prescription. Lupin’s Florida-based facility will focus on inhalation products for the treatment of asthma, allergic rhinitis, chronic obstructive pulmonary diseases and other lung diseases.

“The United States is a world leader in life sciences,” Dr. Zeng said. “Lupin’s facility in Florida demonstrates a commitment to provide high quality and affordable pharmaceuticals to patients all over the world.”

Enterprise Florida President/CEO, Gray Swoope, said “Lupin’s investment in a new research and development laboratory will elevate Florida’s life sciences industry. This expansion helps position the state as the number one place for business. We are proud to see Lupin grow worldwide and find a home in Florida.”

This project is the result of close partnerships between Enterprise Florida, the Greater Fort Lauderdale Alliance, Broward County, CareerSource Florida and the Florida Department of Economic Opportunity.

Florida Department of Economic Opportunity Executive Director Jesse Panuccio said, “Lupin’s selection of South Florida for their research and development facility is an exciting addition to the state’s growing life sciences industry. With the company’s creation of 45 new high-skill jobs, capital investment in the area, and increasing notoriety in their field, this expansion will contribute to Florida’s remarkable economic turnaround story.”

As part of the project, CareerSource Florida has offered Lupin performance-based partial reimbursement grants for employee training through the Quick Response Training program.

Chris Hart IV, President/CEO of CareerSource Florida, said, “We are glad to assist Lupin with its training needs as it brings dozens of high-skill positions to Florida, and excited by the opportunity to be part of a project that leverages the talent of Florida’s growing research community and top-notch universities.”

City of Coral Springs Mayor Vince Boccard said, “We are very excited to welcome Lupin, a transnational pharmaceutical company, to the City of Coral Springs Corporate Park. The City is well positioned to support Lupin’s growth initiative in the specialty pharmaceutical market. We’re open for business and we’re glad Lupin is joining us.”

Bob Swindell, President/CEO of the Greater Fort Lauderdale Alliance said, “We are extremely happy that Lupin decided to expand in Coral Springs and welcome their expansion in Broward County. The company’s decision to grow here is a testament to the strength of the pharmaceutical industry in Broward County and our diverse and talented workforce. Lupin will certainly be an important part of our strong life sciences industry cluster and we wish them every success in their new location.”